Study suggests why an immunotherapy drug works in some melanoma patients but not in others – Cancer Research UK
Cancer Research UK |
Study suggests why an immunotherapy drug works in some melanoma patients but not in others
Cancer Research UK Some immunotherapy drugs, such as pembrolizumab (Keytruda), work by blocking molecules on the surface of immune cells or tumour cells that act as a set of 'brakes' on the immune system. Blocking these molecules, including PD-1 which pembrolizumab … |
